Table 5.
Odds ratios for aspirin, statin, and anti-hypertensive prescription among HIV-Positive Persons (n = 890) compared to Matched Controls (n = 807)a.
| Medication | Unadjusted OR (95% CI) |
Adjusted OR (95% CI) |
p-value |
|---|---|---|---|
| Aspirinb | 0.44 (0.34–0.58) | 0.53 (0.40–0.71) | <0.0001 |
| Statinc | 0.57 (0.45–0.74) | 0.70 (0.53–0.92) | 0.01 |
| Anti- hypertensivesd |
0.51 (0.42–0.62) | 0.63 (0.50–0.79) | <0.0001 |
a
Reference = uninfected persons.
b
Covariates in model for aspirin prescription include diabetes, mean systolic blood pressure, mean high density lipoprotein (HDL), and HIV-infection.
c
Covariates in model for aspirin prescription include diabetes, private insurance, mean total cholesterol, mean LDL-c, mean HDL, and HIV-infection.
d
Covariates in model for anti-hypertensive prescription include diabetes, mean systolic blood pressure, smoking, and HIV-infection.